|
|
Rockwell Medical Reports Third Quarter 2011 Results - istockAnalyst.com (press release) |
|
|
istockAnalyst.com (press release)
3, 2011 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron
|
|
|
Rockwell Medical Reports Third Quarter 2011 Results - MarketWatch (press release) |
|
|
MarketWatch (press release)
SFP delivers iron in a non-invasive, physiologic manner to dialysis patients via dialysate during their regular dialysis treatment. SFP is currently in ongoing Phase III clinical trials (CRUISE-1 and CRUISE-2) and addresses a $600M US market.
|
|
Bhupen Hazarika responds to dialysis, but still critical - Times of India |
|
|
Times of India
A team of doctors, led by intensive care medicine specialist Shalendra Goel, put the icon on dialysis for the second day after both his kidneys failed on Tuesday. Jayanta Narayan Saha, in-charge of media relations at the hospital, said,
|
|
|
Solantic to set up offices in Brentwood - The Tennessean |
|
|
The Tennessean
Before being recruited to lead the company in June, Klein was CEO of Franklin-based Renal Advantage Inc., a dialysis services provider that Solantic's majority owner (private equity firm Welsh, Carson, Anderson & Stowe) sold late last year.
|
|
DaVita, doctors group probed for possible kickback - Denver Post |
|
|
Denver Post
In 2008, DaVita, the nation's largest dialysis provider, sold half-ownership in seven dialysis clinics to Denver Nephrology for $1.89 million. Those clinics generated estimated annual revenues of more than $28 million, according to documents obtained
|
|
|
|
|
<< Start < Prev 601 602 603 604 605 606 607 608 609 610 Next > End >>
|
|
Page 610 of 2630 |